Undervalued Stocks Based On Cash Flows
Résultats
6
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
6 entreprises
| Entreprise | Dernier prix | 7D Retour | Retour 1 an | Capitalisation boursière | Cible des analystes | Évaluation | Croissance | Rendement des dividendes | L'industrie | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ROVI | €57.95 | -0.7% | 2.7% | €3.0b | €74.36 | 16.0 | 12.2% | 1.7% | Pharmaceuticals & Biotech | ||
PANG | €1.55 | 0% | -9.9% | €55.7m | n/a | 3.3 | 96.1% | n/a | Pharmaceuticals & Biotech | ||
PRS | €2.97 | -1.0% | -19.7% | €400.5m | €4.22 | 0.4 | 75.1% | n/a | Media | ||
TUB | €3.09 | 2.5% | -14.8% | €377.2m | €4.14 | 0.6 | 82.9% | 6.6% | Materials | ||
ACX | €18.09 | 0.7% | 68.8% | €4.5b | €18.02 | 83.4 | 34.0% | 3.4% | Materials | ||
ART | €29.00 | 0.7% | 135.8% | €1.7b | €34.25 | 29.8 | 22.8% | 0.6% | Capital Goods |
Page 1 of 1